ClinConnect ClinConnect Logo
Search / Trial NCT06578416

The Development of Stuttering in Young Children

Launched by MICHIGAN STATE UNIVERSITY · Aug 27, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is focused on understanding why some young children who stutter are able to "grow out" of it, while others continue to struggle. Researchers are looking for children aged 3 to 6 years, both those who currently stutter and those who do not, to participate in the study. To be eligible, children should primarily speak English and have no history of certain medical conditions, like neurological diseases or intellectual impairments. They should also pass a hearing test and not be on medications that could affect their performance.

Participants in the study will take part in fun, child-friendly activities while researchers assess their speech and language skills. These activities include describing pictures, speaking in virtual-reality scenarios, and talking while keeping a beat. Throughout the study, researchers will also monitor the children’s brain activity using special caps. This research aims to help us better understand stuttering in young children and could lead to improved support and interventions for those who need it.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria for controls:
  • English as first/primary language
  • No history of neurological disease
  • Normal or corrected visual acuity
  • No medications expected to affect performance
  • No intellectual impairment, autism spectrum disorder, ADHD
  • Age-appropriate scores on speech and language assessment battery
  • Pass hearing screening at 20 dB at 500, 1000, 2000, and 4000, bilaterally
  • Inclusion Criteria for children who stutter:
  • English as first/primary language
  • No history of neurological disease
  • Normal or corrected visual acuity
  • No medications expected to affect performance
  • No intellectual impairment or ASD Scores on speech and language assessments indicating stuttering, phonological (speech sound), or language disorders
  • Pass hearing screening at 20 dB at 500, 1000, 2000, and 4000, bilaterally

About Michigan State University

Michigan State University (MSU) is a leading public research institution dedicated to advancing knowledge and improving health outcomes through innovative clinical trials. With a strong emphasis on interdisciplinary collaboration, MSU integrates cutting-edge research methodologies and expert faculty across various fields to address pressing health challenges. The university's commitment to ethical research practices and participant safety ensures that all clinical trials are conducted with the highest standards of integrity and compliance. By fostering a dynamic environment for scientific inquiry, MSU aims to translate research findings into practical solutions that enhance patient care and contribute to the broader healthcare community.

Locations

East Lansing, Michigan, United States

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported